My watch list
my.bionity.com  
Login  

Phase II Studies

News Phase II Studies

  • Allergy Vaccine Successful

    Biomay announced that a second Phase IIb study has been successfully completed with its third generation grass pollen allergy vaccine BM32. The study was designed to demonstrate the optimal dose regimen to induce an allergen-specific IgG immune response. Correlation of the immunological effects with more

  • BioInvent reports clinical hold on BI-505 phase II study

    BioInvent International has received verbal notice from the U.S. Food and Drug Administration that a full clinical hold (i.e. no further dosing of patients) has been placed on BioInvent’s current clinical Phase II study with the antibody BI-505 in patients with multiple myeloma. BioInvent has not ye more

  • Effectiveness of drug to improve natriuretic peptide levels for chronic heart failure

    Mihai Gheorghiade, M.D., of the Northwestern University Feinberg School of Medicine, Chicago, and colleagues randomly assigned 456 patients with worsening chronic HF and reduced left ventricular ejection fraction to receive placebo or 1 of 4 daily target doses of the medication vericiguat for 12 wee more

All news on phase ii studies

Publications Phase II Studies

All publications on phase ii studies
Related topics

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE